Neurodegenerative diseases, neuropsychiatric diseases, brain aging, amnesia

Amylgen is a privately owned CRO offering a unique combination of validated in vivo models and a full range of biochemical and morphological testing allowing fast and predictive screening of the effects of drugs and nutraceuticals on brain health.
We offer a panel of in vivo rodent models for a variety of CNS disorders like depression, schizophrenia, anxiety and more particularly neurodegenerative diseases like Alzheimer, ALS, and Parkinson. We also propose models allowing to test drugs or nutraceuticals on the aging brain.
Thanks to our background in the Industry, we guarantee satisfaction and provide our services with non-conditional high-quality standards and with full awareness of time-sensitive deadlines in the frame of critical phases of product development.